Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment

Volume: 26, Issue: 5, Pages: 1159 - 1173
Published: May 14, 2020
Abstract
Anthracycline is a mainstay in treatment of many cancers including lymphoma and breast cancer among many others. However, anthracycline treatment can be cardiotoxic. Although anthracycline-induced cardiotoxicity is dose dependent, it can also occur early at the onset of treatment and even up to several years following completion of treatment. This review article focuses on the understanding of mechanisms of anthracycline-induced cardiotoxicity,...
Paper Details
Title
Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment
Published Date
May 14, 2020
Volume
26
Issue
5
Pages
1159 - 1173
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.